TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
NGNE

Neurogene Inc

Healthcare · Biotechnology · —

27.60$ -4.4% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Neurogene Inc (NGNE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 56.5% of the shares are freely tradable; institutional investors hold 110.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 110.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 8.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 56.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 29.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 20Mio.

Largest Shareholders

Institutions

Institutions NGNE
Name Stake (%) Shares Change (%) Date
Samsara BioCapital, LLC 8.58 1,717,127 +0.0 06/30/2026
Casdin Capital, LLC 7.72 1,545,361 +8.8 06/30/2026
Redmile Group, LLC 7.06 1,412,199 -3.2 06/30/2026
RTW INVESTMENTS, LLC 6.81 1,362,456 +0.0 06/30/2026
EcoR1 Capital, LLC 6.35 1,271,342 +0.0 06/30/2026
BlackRock Inc 5.29 1,057,983 +5.3 06/30/2026
Baker Bros Advisors LP 4.96 991,691 +0.0 06/30/2026
Balyasny Asset Management LLC 4.09 818,706 +14.0 06/30/2026
Trails Edge Capital Partners, LP 3.57 714,885 -8.7 06/30/2026
The Toronto-Dominion Bank 3.40 681,337 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings NGNE
Person Role Shares Value As of Type
McMinn Rachel Chief Executive Officer 1,345,063 37,123,739 $ Sep 22, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 22, 2026 McMinn Rachel Chief Executive Officer Other 756 25.32 19,142

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?